Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Leukemia & Lymphoma|July 7, 2020
Primary refractory multiple myeloma: a real-world experience with 85 casesArtur Jurczyszyn, Anna Waszczuk-Gajda, Jorge J Castillo, et al.
Oncology Letters|December 3, 2019
High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study GroupIwona Hus, Joanna Mańko, Dariusz Jawniak, et al.
Cancers|July 27, 2024
Stem Cell Mobilization Performed with Different Doses of Cytarabine in Plasma Cell Myeloma Patients Relapsing after Previous Autologous Hematopoietic Cell Transplantation-A Multicenter Report by the Polish Myeloma Study GroupJoanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Magdalena Topczewska, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 30, 2021
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter AnalysisArtur Jurczyszyn, Jorge J Castillo, Magdalena Olszewska-Szopa, et al.
Leukemia & Lymphoma|August 1, 2025
Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL - real-life data analysis of the Polish Adult leukemia groupKlaudia Zielonka, Błażej Izdebski, Joanna Drozd-Sokołowska, et al.
International Journal of Cancer|July 13, 2022
Response to anti-SARS-CoV-2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patientsJoanna Zaleska, Paulina Kwasnik, Magdalena Paziewska, et al.
Leukemia & Lymphoma|July 3, 2018
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patientsArtur Jurczyszyn, Jorge J Castillo, Irit Avivi, et al.
British Journal of Haematology|January 10, 2018
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patientsArtur Jurczyszyn, Jakub Radocha, Julio Davila, et al.
Leukemia|December 21, 2023
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinibKaterina Machova Polakova, Ali Albeer, Vaclava Polivkova, et al.
American Journal of Hematology|February 20, 2020
A multicenter retrospective study of 223 patients with t(14;16) in multiple myelomaSarah Goldman-Mazur, Artur Jurczyszyn, Jorge J Castillo, et al.
Pageof 8